Newcardio, Inc. (NWCI)

[H8ster]

Mid-Atlantic Bio Conference


I find this to be fantastic!
This is a conference that Frederick Frank, whom is currently working with NWCI in finding a strategic partner, will be addressing in late October.

http://midatlanticbio.org/biotechnology-...

WASHINGTON (September 3, 2010)—Frederick Frank, one of the most significant dealmakers in the biotech and pharma industry’s history and current vice chairman of Peter J. Solomon Company, will address the 2010 Mid-Atlantic Bio Conference (Oct. 27-29), on October 28, at the North Bethesda Marriott Convention Center in Bethesda, Md.

Now in its sixth year, Mid-Atlantic Bio is the only globally-focused, yet regionally-based, event to combine components of a bioscience industry convention with an investor conference under one roof. More than 800 national and international industry leaders, government representatives, executives, researchers, investors, entrepreneurs, and professional services firms will gather to promote networking, business expansion, and technical-knowledge sharing. Home to industry-critical regulatory and research agencies; federal policymaking; and business and scientific centers of excellence, the Mid-Atlantic is a unique center for the global bioscience industry.

Mr. Frank is credited as one of the leading investment bankers worldwide for pharmaceutical, biotechnology, healthcare services, medical device and nutraceutical company mergers, acquisitions, strategic alliances and equity fundraising. With his wealth of experience, Mr. Frank will provide insight to how the industry is coping in today’s volatile economic climate and what needs to evolve to compete in today’s markets.

In addition to Mr. Frank’s role as vice chairman of Peter J. Solomon Company, he is also a member of its Mergers and Acquisitions Group, and co-heads PJSC’s global pharmaceutical and life sciences practice. He was formerly vice chairman of Barclays Capital, and previous to that, was vice chairman and a director of Lehman Brothers Inc. Before joining Lehman Brothers as partner, Mr. Frank was co-director of research, as well as vice president and director of Smith, Barney & Co. Incorporated.

“Our regional biotechnology industry is increasingly recognized as a hub for scientific progress and excellence,” said Mid-Atlantic Venture Association (MAVA) Executive Director Julia Spicer. “Mid-Atlantic Bio brings together the region’s biotechnology community to offer one of the most in-depth networking and educational forums for the life sciences industry. Conference participants leave the meeting with the right connections to build their businesses.”